nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—HTR7—enteric nervous system—Crohn's disease	0.0568	0.234	CbGeAlD
Iloperidone—HTR7—myenteric nerve plexus—Crohn's disease	0.043	0.177	CbGeAlD
Iloperidone—HTR2A—enteric nervous system—Crohn's disease	0.0354	0.146	CbGeAlD
Iloperidone—HTR2A—myenteric nerve plexus—Crohn's disease	0.0268	0.111	CbGeAlD
Iloperidone—Eye swelling—Mesalazine—Crohn's disease	0.0156	0.0356	CcSEcCtD
Iloperidone—Haematocrit decreased—Mesalazine—Crohn's disease	0.0136	0.0312	CcSEcCtD
Iloperidone—Duodenal ulcer—Mesalazine—Crohn's disease	0.0105	0.024	CcSEcCtD
Iloperidone—Faecal incontinence—Mesalazine—Crohn's disease	0.0101	0.023	CcSEcCtD
Iloperidone—Mouth ulceration—Mercaptopurine—Crohn's disease	0.00846	0.0193	CcSEcCtD
Iloperidone—Cholelithiasis—Mesalazine—Crohn's disease	0.00817	0.0187	CcSEcCtD
Iloperidone—HTR7—mouth—Crohn's disease	0.00736	0.0303	CbGeAlD
Iloperidone—Metrorrhagia—Mesalazine—Crohn's disease	0.00711	0.0162	CcSEcCtD
Iloperidone—Menorrhagia—Mesalazine—Crohn's disease	0.00686	0.0157	CcSEcCtD
Iloperidone—Rhinorrhoea—Mesalazine—Crohn's disease	0.00627	0.0143	CcSEcCtD
Iloperidone—Breast disorder—Mercaptopurine—Crohn's disease	0.00614	0.014	CcSEcCtD
Iloperidone—Blood disorder—Mesalazine—Crohn's disease	0.00608	0.0139	CcSEcCtD
Iloperidone—Delirium—Mesalazine—Crohn's disease	0.0059	0.0135	CcSEcCtD
Iloperidone—Breast pain—Mesalazine—Crohn's disease	0.00582	0.0133	CcSEcCtD
Iloperidone—Amenorrhoea—Mesalazine—Crohn's disease	0.00578	0.0132	CcSEcCtD
Iloperidone—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00566	0.0129	CcSEcCtD
Iloperidone—Stomatitis—Mercaptopurine—Crohn's disease	0.0051	0.0117	CcSEcCtD
Iloperidone—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00495	0.0113	CcSEcCtD
Iloperidone—Menstruation irregular—Prednisone—Crohn's disease	0.00485	0.0111	CcSEcCtD
Iloperidone—SIGMAR1—smooth muscle tissue—Crohn's disease	0.00483	0.0199	CbGeAlD
Iloperidone—Dry eye—Mesalazine—Crohn's disease	0.00469	0.0107	CcSEcCtD
Iloperidone—Mouth ulceration—Mesalazine—Crohn's disease	0.00459	0.0105	CcSEcCtD
Iloperidone—SIGMAR1—mammalian vulva—Crohn's disease	0.00435	0.0179	CbGeAlD
Iloperidone—HTR7—epithelium—Crohn's disease	0.00428	0.0177	CbGeAlD
Iloperidone—Hypothyroidism—Prednisone—Crohn's disease	0.00419	0.00956	CcSEcCtD
Iloperidone—ADRA1A—epithelium—Crohn's disease	0.00413	0.017	CbGeAlD
Iloperidone—HTR7—smooth muscle tissue—Crohn's disease	0.00413	0.017	CbGeAlD
Iloperidone—Malnutrition—Mercaptopurine—Crohn's disease	0.00409	0.00935	CcSEcCtD
Iloperidone—Renal failure acute—Mesalazine—Crohn's disease	0.00399	0.00912	CcSEcCtD
Iloperidone—Libido decreased—Mesalazine—Crohn's disease	0.00397	0.00908	CcSEcCtD
Iloperidone—Increased appetite—Mesalazine—Crohn's disease	0.00392	0.00897	CcSEcCtD
Iloperidone—Thirst—Mesalazine—Crohn's disease	0.00387	0.00885	CcSEcCtD
Iloperidone—Delusion—Prednisone—Crohn's disease	0.0038	0.00867	CcSEcCtD
Iloperidone—Anaemia—Mercaptopurine—Crohn's disease	0.00378	0.00864	CcSEcCtD
Iloperidone—Lethargy—Mesalazine—Crohn's disease	0.00376	0.0086	CcSEcCtD
Iloperidone—Mania—Prednisone—Crohn's disease	0.00369	0.00844	CcSEcCtD
Iloperidone—Leukopenia—Mercaptopurine—Crohn's disease	0.00366	0.00837	CcSEcCtD
Iloperidone—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00366	0.00836	CcSEcCtD
Iloperidone—Affect lability—Mesalazine—Crohn's disease	0.00363	0.00829	CcSEcCtD
Iloperidone—Mood swings—Mesalazine—Crohn's disease	0.00349	0.00798	CcSEcCtD
Iloperidone—Arthralgia—Mercaptopurine—Crohn's disease	0.00348	0.00796	CcSEcCtD
Iloperidone—ADRA2C—mammalian vulva—Crohn's disease	0.00341	0.0141	CbGeAlD
Iloperidone—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00337	0.00769	CcSEcCtD
Iloperidone—Abdominal discomfort—Azathioprine—Crohn's disease	0.00335	0.00766	CcSEcCtD
Iloperidone—Oedema—Mercaptopurine—Crohn's disease	0.00334	0.00763	CcSEcCtD
Iloperidone—Breast disorder—Mesalazine—Crohn's disease	0.00333	0.00761	CcSEcCtD
Iloperidone—Nasopharyngitis—Mesalazine—Crohn's disease	0.0033	0.00753	CcSEcCtD
Iloperidone—Gastritis—Mesalazine—Crohn's disease	0.00326	0.00745	CcSEcCtD
Iloperidone—HTR7—digestive system—Crohn's disease	0.00326	0.0134	CbGeAlD
Iloperidone—Endocrine disorder—Prednisone—Crohn's disease	0.00324	0.00741	CcSEcCtD
Iloperidone—HRH1—epithelium—Crohn's disease	0.0032	0.0132	CbGeAlD
Iloperidone—Asthma—Mesalazine—Crohn's disease	0.00319	0.00728	CcSEcCtD
Iloperidone—ADRA1A—lymphoid tissue—Crohn's disease	0.00318	0.0131	CbGeAlD
Iloperidone—Delirium—Prednisone—Crohn's disease	0.00312	0.00714	CcSEcCtD
Iloperidone—HRH1—smooth muscle tissue—Crohn's disease	0.00308	0.0127	CbGeAlD
Iloperidone—Amenorrhoea—Prednisone—Crohn's disease	0.00306	0.00699	CcSEcCtD
Iloperidone—Abdominal discomfort—Mesalazine—Crohn's disease	0.00305	0.00698	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00304	0.00695	CcSEcCtD
Iloperidone—Dysuria—Mesalazine—Crohn's disease	0.00298	0.00681	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00296	0.00677	CcSEcCtD
Iloperidone—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00295	0.00674	CcSEcCtD
Iloperidone—Pollakiuria—Mesalazine—Crohn's disease	0.00294	0.00673	CcSEcCtD
Iloperidone—Weight increased—Mesalazine—Crohn's disease	0.0029	0.00663	CcSEcCtD
Iloperidone—Weight decreased—Mesalazine—Crohn's disease	0.00288	0.00659	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00288	0.00659	CcSEcCtD
Iloperidone—Cataract—Prednisone—Crohn's disease	0.00282	0.00645	CcSEcCtD
Iloperidone—HRH1—mammalian vulva—Crohn's disease	0.00277	0.0114	CbGeAlD
Iloperidone—Stomatitis—Mesalazine—Crohn's disease	0.00277	0.00633	CcSEcCtD
Iloperidone—Conjunctivitis—Mesalazine—Crohn's disease	0.00276	0.00631	CcSEcCtD
Iloperidone—ADRA2A—mammalian vulva—Crohn's disease	0.00272	0.0112	CbGeAlD
Iloperidone—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00269	0.00614	CcSEcCtD
Iloperidone—Epistaxis—Mesalazine—Crohn's disease	0.00268	0.00612	CcSEcCtD
Iloperidone—HTR2A—epithelium—Crohn's disease	0.00267	0.011	CbGeAlD
Iloperidone—Body temperature increased—Mercaptopurine—Crohn's disease	0.00264	0.00603	CcSEcCtD
Iloperidone—CYP1A2—digestive system—Crohn's disease	0.0026	0.0107	CbGeAlD
Iloperidone—HTR2A—smooth muscle tissue—Crohn's disease	0.00257	0.0106	CbGeAlD
Iloperidone—Fluid retention—Prednisone—Crohn's disease	0.00255	0.00583	CcSEcCtD
Iloperidone—Mediastinal disorder—Azathioprine—Crohn's disease	0.00252	0.00577	CcSEcCtD
Iloperidone—Urinary tract disorder—Mesalazine—Crohn's disease	0.00252	0.00575	CcSEcCtD
Iloperidone—CYP3A5—digestive system—Crohn's disease	0.00251	0.0103	CbGeAlD
Iloperidone—Connective tissue disorder—Mesalazine—Crohn's disease	0.00251	0.00573	CcSEcCtD
Iloperidone—Arrhythmia—Azathioprine—Crohn's disease	0.0025	0.00572	CcSEcCtD
Iloperidone—Urethral disorder—Mesalazine—Crohn's disease	0.0025	0.00571	CcSEcCtD
Iloperidone—HRH1—digestive system—Crohn's disease	0.00243	0.01	CbGeAlD
Iloperidone—Eye disorder—Mesalazine—Crohn's disease	0.00238	0.00545	CcSEcCtD
Iloperidone—Tinnitus—Mesalazine—Crohn's disease	0.00238	0.00543	CcSEcCtD
Iloperidone—CYP2E1—lymphoid tissue—Crohn's disease	0.00237	0.00975	CbGeAlD
Iloperidone—Cardiac disorder—Mesalazine—Crohn's disease	0.00237	0.00541	CcSEcCtD
Iloperidone—CYP2E1—digestive system—Crohn's disease	0.00234	0.00964	CbGeAlD
Iloperidone—Angiopathy—Mesalazine—Crohn's disease	0.00231	0.00529	CcSEcCtD
Iloperidone—Mediastinal disorder—Mesalazine—Crohn's disease	0.0023	0.00525	CcSEcCtD
Iloperidone—Diarrhoea—Mercaptopurine—Crohn's disease	0.00228	0.00522	CcSEcCtD
Iloperidone—Anaemia—Azathioprine—Crohn's disease	0.00225	0.00515	CcSEcCtD
Iloperidone—Mental disorder—Mesalazine—Crohn's disease	0.00223	0.00511	CcSEcCtD
Iloperidone—Leukopenia—Azathioprine—Crohn's disease	0.00218	0.00499	CcSEcCtD
Iloperidone—SIGMAR1—lymph node—Crohn's disease	0.00218	0.00898	CbGeAlD
Iloperidone—Muscle spasms—Mesalazine—Crohn's disease	0.00213	0.00488	CcSEcCtD
Iloperidone—Rash—Mercaptopurine—Crohn's disease	0.0021	0.00481	CcSEcCtD
Iloperidone—Dermatitis—Mercaptopurine—Crohn's disease	0.0021	0.00481	CcSEcCtD
Iloperidone—Vision blurred—Mesalazine—Crohn's disease	0.00209	0.00478	CcSEcCtD
Iloperidone—Tremor—Mesalazine—Crohn's disease	0.00208	0.00475	CcSEcCtD
Iloperidone—Increased appetite—Prednisone—Crohn's disease	0.00208	0.00474	CcSEcCtD
Iloperidone—Amnesia—Prednisone—Crohn's disease	0.00208	0.00474	CcSEcCtD
Iloperidone—Myalgia—Azathioprine—Crohn's disease	0.00207	0.00474	CcSEcCtD
Iloperidone—Arthralgia—Azathioprine—Crohn's disease	0.00207	0.00474	CcSEcCtD
Iloperidone—Anaemia—Mesalazine—Crohn's disease	0.00205	0.00469	CcSEcCtD
Iloperidone—HTR2A—digestive system—Crohn's disease	0.00203	0.00837	CbGeAlD
Iloperidone—Cardiac failure—Prednisone—Crohn's disease	0.002	0.00457	CcSEcCtD
Iloperidone—Vertigo—Mesalazine—Crohn's disease	0.00199	0.00456	CcSEcCtD
Iloperidone—Lethargy—Prednisone—Crohn's disease	0.00199	0.00455	CcSEcCtD
Iloperidone—Leukopenia—Mesalazine—Crohn's disease	0.00199	0.00454	CcSEcCtD
Iloperidone—Nausea—Mercaptopurine—Crohn's disease	0.00198	0.00453	CcSEcCtD
Iloperidone—Infection—Azathioprine—Crohn's disease	0.00198	0.00452	CcSEcCtD
Iloperidone—Palpitations—Mesalazine—Crohn's disease	0.00196	0.00448	CcSEcCtD
Iloperidone—Affect lability—Prednisone—Crohn's disease	0.00192	0.00439	CcSEcCtD
Iloperidone—Psychotic disorder—Prednisone—Crohn's disease	0.0019	0.00435	CcSEcCtD
Iloperidone—Arthralgia—Mesalazine—Crohn's disease	0.00189	0.00432	CcSEcCtD
Iloperidone—Myalgia—Mesalazine—Crohn's disease	0.00189	0.00432	CcSEcCtD
Iloperidone—CYP3A4—digestive system—Crohn's disease	0.00188	0.00775	CbGeAlD
Iloperidone—Hypotension—Azathioprine—Crohn's disease	0.00186	0.00425	CcSEcCtD
Iloperidone—CYP2D6—digestive system—Crohn's disease	0.00185	0.00763	CbGeAlD
Iloperidone—Dry mouth—Mesalazine—Crohn's disease	0.00185	0.00422	CcSEcCtD
Iloperidone—Mood swings—Prednisone—Crohn's disease	0.00185	0.00422	CcSEcCtD
Iloperidone—Confusional state—Mesalazine—Crohn's disease	0.00183	0.00417	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00181	0.00414	CcSEcCtD
Iloperidone—Oedema—Mesalazine—Crohn's disease	0.00181	0.00414	CcSEcCtD
Iloperidone—Infection—Mesalazine—Crohn's disease	0.0018	0.00411	CcSEcCtD
Iloperidone—Nervous system disorder—Mesalazine—Crohn's disease	0.00178	0.00406	CcSEcCtD
Iloperidone—Hypokalaemia—Prednisone—Crohn's disease	0.00177	0.00406	CcSEcCtD
Iloperidone—Tachycardia—Mesalazine—Crohn's disease	0.00177	0.00404	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00172	0.00392	CcSEcCtD
Iloperidone—ADRA2C—lymph node—Crohn's disease	0.00171	0.00705	CbGeAlD
Iloperidone—Hypotension—Mesalazine—Crohn's disease	0.00169	0.00387	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00165	0.00377	CcSEcCtD
Iloperidone—Feeling abnormal—Azathioprine—Crohn's disease	0.00164	0.00375	CcSEcCtD
Iloperidone—Paraesthesia—Mesalazine—Crohn's disease	0.00163	0.00372	CcSEcCtD
Iloperidone—Dyspnoea—Mesalazine—Crohn's disease	0.00162	0.00369	CcSEcCtD
Iloperidone—Somnolence—Mesalazine—Crohn's disease	0.00161	0.00368	CcSEcCtD
Iloperidone—Body temperature increased—Azathioprine—Crohn's disease	0.00157	0.00359	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00156	0.00357	CcSEcCtD
Iloperidone—Fatigue—Mesalazine—Crohn's disease	0.00156	0.00357	CcSEcCtD
Iloperidone—Erectile dysfunction—Prednisone—Crohn's disease	0.00155	0.00355	CcSEcCtD
Iloperidone—Weight increased—Prednisone—Crohn's disease	0.00153	0.00351	CcSEcCtD
Iloperidone—Weight decreased—Prednisone—Crohn's disease	0.00152	0.00348	CcSEcCtD
Iloperidone—Feeling abnormal—Mesalazine—Crohn's disease	0.00149	0.00341	CcSEcCtD
Iloperidone—Body temperature increased—Mesalazine—Crohn's disease	0.00143	0.00327	CcSEcCtD
Iloperidone—HRH1—lymph node—Crohn's disease	0.00139	0.00573	CbGeAlD
Iloperidone—ADRA2A—lymph node—Crohn's disease	0.00136	0.00563	CbGeAlD
Iloperidone—Diarrhoea—Azathioprine—Crohn's disease	0.00136	0.00311	CcSEcCtD
Iloperidone—Connective tissue disorder—Prednisone—Crohn's disease	0.00133	0.00303	CcSEcCtD
Iloperidone—Dizziness—Azathioprine—Crohn's disease	0.00132	0.00301	CcSEcCtD
Iloperidone—Asthenia—Mesalazine—Crohn's disease	0.0013	0.00297	CcSEcCtD
Iloperidone—Eye disorder—Prednisone—Crohn's disease	0.00126	0.00288	CcSEcCtD
Iloperidone—Rash—Azathioprine—Crohn's disease	0.00125	0.00287	CcSEcCtD
Iloperidone—Dermatitis—Azathioprine—Crohn's disease	0.00125	0.00286	CcSEcCtD
Iloperidone—Diarrhoea—Mesalazine—Crohn's disease	0.00124	0.00283	CcSEcCtD
Iloperidone—Angiopathy—Prednisone—Crohn's disease	0.00122	0.0028	CcSEcCtD
Iloperidone—Arrhythmia—Prednisone—Crohn's disease	0.00121	0.00275	CcSEcCtD
Iloperidone—Dizziness—Mesalazine—Crohn's disease	0.0012	0.00274	CcSEcCtD
Iloperidone—Mental disorder—Prednisone—Crohn's disease	0.00118	0.0027	CcSEcCtD
Iloperidone—Nausea—Azathioprine—Crohn's disease	0.00118	0.0027	CcSEcCtD
Iloperidone—Malnutrition—Prednisone—Crohn's disease	0.00117	0.00268	CcSEcCtD
Iloperidone—Rash—Mesalazine—Crohn's disease	0.00114	0.00261	CcSEcCtD
Iloperidone—Dermatitis—Mesalazine—Crohn's disease	0.00114	0.00261	CcSEcCtD
Iloperidone—Vision blurred—Prednisone—Crohn's disease	0.00111	0.00253	CcSEcCtD
Iloperidone—Anaemia—Prednisone—Crohn's disease	0.00109	0.00248	CcSEcCtD
Iloperidone—Agitation—Prednisone—Crohn's disease	0.00108	0.00247	CcSEcCtD
Iloperidone—Nausea—Mesalazine—Crohn's disease	0.00108	0.00246	CcSEcCtD
Iloperidone—Vertigo—Prednisone—Crohn's disease	0.00106	0.00241	CcSEcCtD
Iloperidone—Myalgia—Prednisone—Crohn's disease	0.001	0.00229	CcSEcCtD
Iloperidone—Arthralgia—Prednisone—Crohn's disease	0.001	0.00229	CcSEcCtD
Iloperidone—Oedema—Prednisone—Crohn's disease	0.000958	0.00219	CcSEcCtD
Iloperidone—Infection—Prednisone—Crohn's disease	0.000952	0.00218	CcSEcCtD
Iloperidone—Nervous system disorder—Prednisone—Crohn's disease	0.00094	0.00215	CcSEcCtD
Iloperidone—Tachycardia—Prednisone—Crohn's disease	0.000935	0.00214	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000873	0.002	CcSEcCtD
Iloperidone—Paraesthesia—Prednisone—Crohn's disease	0.000861	0.00197	CcSEcCtD
Iloperidone—Fatigue—Prednisone—Crohn's disease	0.000826	0.00189	CcSEcCtD
Iloperidone—Feeling abnormal—Prednisone—Crohn's disease	0.00079	0.00181	CcSEcCtD
Iloperidone—Body temperature increased—Prednisone—Crohn's disease	0.000758	0.00173	CcSEcCtD
Iloperidone—Asthenia—Prednisone—Crohn's disease	0.000688	0.00157	CcSEcCtD
Iloperidone—Diarrhoea—Prednisone—Crohn's disease	0.000656	0.0015	CcSEcCtD
Iloperidone—Dizziness—Prednisone—Crohn's disease	0.000634	0.00145	CcSEcCtD
Iloperidone—Rash—Prednisone—Crohn's disease	0.000604	0.00138	CcSEcCtD
Iloperidone—Dermatitis—Prednisone—Crohn's disease	0.000604	0.00138	CcSEcCtD
Iloperidone—Nausea—Prednisone—Crohn's disease	0.000569	0.0013	CcSEcCtD
Iloperidone—HTR2A—Signaling Pathways—RBX1—Crohn's disease	7.38e-05	0.000231	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	7.38e-05	0.000231	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—RBX1—Crohn's disease	7.36e-05	0.00023	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—CXCL8—Crohn's disease	7.33e-05	0.000229	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PTGER4—Crohn's disease	7.3e-05	0.000228	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—JAK2—Crohn's disease	7.29e-05	0.000228	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	7.27e-05	0.000227	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	7.26e-05	0.000227	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	7.26e-05	0.000227	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—UBE2D1—Crohn's disease	7.25e-05	0.000227	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	7.24e-05	0.000226	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—SMAD3—Crohn's disease	7.24e-05	0.000226	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—SMAD3—Crohn's disease	7.23e-05	0.000226	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—JAK2—Crohn's disease	7.23e-05	0.000226	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	7.23e-05	0.000226	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	7.23e-05	0.000226	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—SOCS1—Crohn's disease	7.22e-05	0.000226	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—SMAD3—Crohn's disease	7.18e-05	0.000225	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	7.18e-05	0.000225	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PTGER4—Crohn's disease	7.17e-05	0.000224	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—GPX4—Crohn's disease	7.15e-05	0.000224	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—JAK2—Crohn's disease	7.13e-05	0.000223	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—SOCS1—Crohn's disease	7.12e-05	0.000223	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	7.11e-05	0.000222	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL3—Crohn's disease	7.08e-05	0.000221	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL3—Crohn's disease	7.05e-05	0.00022	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	7.04e-05	0.00022	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	7.03e-05	0.00022	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—CXCL8—Crohn's disease	6.96e-05	0.000218	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—CXCL8—Crohn's disease	6.95e-05	0.000217	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—SMAD3—Crohn's disease	6.92e-05	0.000216	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—CXCL8—Crohn's disease	6.91e-05	0.000216	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—GCKR—Crohn's disease	6.9e-05	0.000216	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—TYK2—Crohn's disease	6.88e-05	0.000215	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL3—Crohn's disease	6.85e-05	0.000214	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	6.85e-05	0.000214	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	6.82e-05	0.000213	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—TYK2—Crohn's disease	6.79e-05	0.000212	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	6.71e-05	0.00021	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL2RA—Crohn's disease	6.7e-05	0.00021	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL2RA—Crohn's disease	6.7e-05	0.000209	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—CXCL8—Crohn's disease	6.66e-05	0.000208	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL2RA—Crohn's disease	6.65e-05	0.000208	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	6.63e-05	0.000207	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	6.6e-05	0.000206	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	6.6e-05	0.000206	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	6.58e-05	0.000206	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—JAK2—Crohn's disease	6.57e-05	0.000205	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	6.54e-05	0.000204	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	6.51e-05	0.000204	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—JAK2—Crohn's disease	6.48e-05	0.000203	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	6.47e-05	0.000202	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—FADS1—Crohn's disease	6.47e-05	0.000202	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	6.46e-05	0.000202	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL2RA—Crohn's disease	6.41e-05	0.0002	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—MTMR3—Crohn's disease	6.41e-05	0.0002	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—RIPK2—Crohn's disease	6.38e-05	0.000199	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	6.34e-05	0.000198	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	6.28e-05	0.000196	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—RIPK2—Crohn's disease	6.26e-05	0.000196	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—SMAD3—Crohn's disease	6.23e-05	0.000195	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL3—Crohn's disease	6.22e-05	0.000194	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	6.22e-05	0.000194	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	6.21e-05	0.000194	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	6.19e-05	0.000193	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	6.18e-05	0.000193	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—SMAD3—Crohn's disease	6.15e-05	0.000192	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	6.14e-05	0.000192	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL3—Crohn's disease	6.12e-05	0.000191	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL3—Crohn's disease	6.11e-05	0.000191	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GPX4—Crohn's disease	6.06e-05	0.000189	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	6.02e-05	0.000188	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	6.02e-05	0.000188	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	6.01e-05	0.000188	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	5.99e-05	0.000187	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL3—Crohn's disease	5.99e-05	0.000187	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	5.92e-05	0.000185	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	5.92e-05	0.000185	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	5.91e-05	0.000185	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	5.91e-05	0.000185	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	5.89e-05	0.000184	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	5.89e-05	0.000184	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GCKR—Crohn's disease	5.85e-05	0.000183	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	5.8e-05	0.000181	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL2RA—Crohn's disease	5.77e-05	0.00018	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	5.73e-05	0.000179	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	5.71e-05	0.000179	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL2RA—Crohn's disease	5.69e-05	0.000178	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	5.67e-05	0.000177	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	5.65e-05	0.000177	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	5.65e-05	0.000177	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	5.62e-05	0.000176	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL3—Crohn's disease	5.57e-05	0.000174	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	5.49e-05	0.000172	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	5.46e-05	0.000171	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	5.46e-05	0.000171	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SOCS1—Crohn's disease	5.45e-05	0.00017	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	5.39e-05	0.000168	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	5.37e-05	0.000168	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	5.36e-05	0.000168	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	5.36e-05	0.000168	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	5.36e-05	0.000168	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SOCS1—Crohn's disease	5.35e-05	0.000167	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	5.33e-05	0.000167	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	5.26e-05	0.000164	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	5.25e-05	0.000164	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—TYK2—Crohn's disease	5.2e-05	0.000162	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	5.19e-05	0.000162	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	5.15e-05	0.000161	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	5.13e-05	0.00016	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	5.11e-05	0.00016	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—TYK2—Crohn's disease	5.1e-05	0.00016	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	5.01e-05	0.000157	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—FADS1—Crohn's disease	4.99e-05	0.000156	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	4.99e-05	0.000156	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	4.98e-05	0.000156	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	4.96e-05	0.000155	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—JAK2—Crohn's disease	4.96e-05	0.000155	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	4.94e-05	0.000154	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	4.9e-05	0.000153	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	4.89e-05	0.000153	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	4.89e-05	0.000153	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	4.88e-05	0.000153	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	4.88e-05	0.000153	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—JAK2—Crohn's disease	4.87e-05	0.000152	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	4.8e-05	0.00015	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	4.8e-05	0.00015	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	4.78e-05	0.000149	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TYK2—Crohn's disease	4.72e-05	0.000148	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TYK2—Crohn's disease	4.72e-05	0.000148	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SMAD3—Crohn's disease	4.71e-05	0.000147	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TYK2—Crohn's disease	4.69e-05	0.000147	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GPX4—Crohn's disease	4.67e-05	0.000146	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	4.65e-05	0.000145	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	4.63e-05	0.000145	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SMAD3—Crohn's disease	4.62e-05	0.000144	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	4.53e-05	0.000142	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	4.52e-05	0.000141	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TYK2—Crohn's disease	4.52e-05	0.000141	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GCKR—Crohn's disease	4.51e-05	0.000141	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—JAK2—Crohn's disease	4.51e-05	0.000141	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—JAK2—Crohn's disease	4.5e-05	0.000141	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—JAK2—Crohn's disease	4.47e-05	0.00014	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	4.46e-05	0.000139	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	4.45e-05	0.000139	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	4.44e-05	0.000139	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	4.44e-05	0.000139	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	4.36e-05	0.000136	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL2RA—Crohn's disease	4.36e-05	0.000136	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—JAK2—Crohn's disease	4.31e-05	0.000135	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	4.29e-05	0.000134	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL2RA—Crohn's disease	4.28e-05	0.000134	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—ALB—Crohn's disease	4.28e-05	0.000134	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	4.21e-05	0.000132	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	4.2e-05	0.000131	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.18e-05	0.000131	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—ALB—Crohn's disease	4.15e-05	0.00013	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CXCL8—Crohn's disease	4.11e-05	0.000129	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CXCL8—Crohn's disease	4.11e-05	0.000128	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	4.08e-05	0.000128	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TYK2—Crohn's disease	4.07e-05	0.000127	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	4.05e-05	0.000127	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TYK2—Crohn's disease	4.01e-05	0.000125	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CXCL8—Crohn's disease	3.93e-05	0.000123	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—IL6—Crohn's disease	3.91e-05	0.000122	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—IL6—Crohn's disease	3.91e-05	0.000122	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	3.9e-05	0.000122	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—IL6—Crohn's disease	3.88e-05	0.000121	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—JAK2—Crohn's disease	3.88e-05	0.000121	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—JAK2—Crohn's disease	3.83e-05	0.00012	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PTGS2—Crohn's disease	3.74e-05	0.000117	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—IL6—Crohn's disease	3.74e-05	0.000117	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.66e-05	0.000114	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PTGS2—Crohn's disease	3.63e-05	0.000114	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CXCL8—Crohn's disease	3.54e-05	0.000111	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TYK2—Crohn's disease	3.5e-05	0.000109	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CXCL8—Crohn's disease	3.49e-05	0.000109	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TYK2—Crohn's disease	3.48e-05	0.000109	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	3.38e-05	0.000106	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—ALB—Crohn's disease	3.37e-05	0.000105	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—IL6—Crohn's disease	3.37e-05	0.000105	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—JAK2—Crohn's disease	3.34e-05	0.000104	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—IL6—Crohn's disease	3.32e-05	0.000104	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—JAK2—Crohn's disease	3.32e-05	0.000104	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—STAT3—Crohn's disease	3.31e-05	0.000103	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—STAT3—Crohn's disease	3.3e-05	0.000103	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—STAT3—Crohn's disease	3.28e-05	0.000103	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	3.23e-05	0.000101	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—STAT3—Crohn's disease	3.16e-05	9.89e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—ALB—Crohn's disease	3.1e-05	9.68e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—ALB—Crohn's disease	3.09e-05	9.66e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TYK2—Crohn's disease	3.07e-05	9.6e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	3.04e-05	9.52e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	3.03e-05	9.47e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TYK2—Crohn's disease	3.02e-05	9.44e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TYK2—Crohn's disease	3.01e-05	9.42e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	2.96e-05	9.25e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PTGS2—Crohn's disease	2.95e-05	9.22e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	2.95e-05	9.21e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—JAK2—Crohn's disease	2.93e-05	9.16e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL6—Crohn's disease	2.89e-05	9.05e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—JAK2—Crohn's disease	2.88e-05	9.01e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL6—Crohn's disease	2.88e-05	9e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—JAK2—Crohn's disease	2.88e-05	8.99e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—STAT3—Crohn's disease	2.85e-05	8.9e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	2.82e-05	8.82e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—STAT3—Crohn's disease	2.81e-05	8.78e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	2.8e-05	8.76e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	2.75e-05	8.59e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PTGS2—Crohn's disease	2.71e-05	8.47e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PTGS2—Crohn's disease	2.7e-05	8.45e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCL8—Crohn's disease	2.67e-05	8.36e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.63e-05	8.22e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCL8—Crohn's disease	2.62e-05	8.2e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	2.62e-05	8.2e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	2.58e-05	8.05e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6—Crohn's disease	2.54e-05	7.95e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.5e-05	7.82e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6—Crohn's disease	2.5e-05	7.8e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	2.45e-05	7.66e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.45e-05	7.65e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—STAT3—Crohn's disease	2.44e-05	7.61e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	2.39e-05	7.48e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	2.37e-05	7.41e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6—Crohn's disease	2.31e-05	7.22e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6—Crohn's disease	2.31e-05	7.21e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6—Crohn's disease	2.29e-05	7.17e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	2.28e-05	7.11e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6—Crohn's disease	2.21e-05	6.91e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ALB—Crohn's disease	2.2e-05	6.87e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—STAT3—Crohn's disease	2.15e-05	6.72e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—STAT3—Crohn's disease	2.11e-05	6.61e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—STAT3—Crohn's disease	2.11e-05	6.6e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	2.07e-05	6.47e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6—Crohn's disease	1.99e-05	6.22e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6—Crohn's disease	1.96e-05	6.13e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	1.92e-05	6.02e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.92e-05	6.01e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ALB—Crohn's disease	1.86e-05	5.82e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6—Crohn's disease	1.71e-05	5.35e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6—Crohn's disease	1.7e-05	5.32e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6—Crohn's disease	1.65e-05	5.17e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.63e-05	5.09e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6—Crohn's disease	1.5e-05	4.69e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.48e-05	4.62e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6—Crohn's disease	1.47e-05	4.61e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6—Crohn's disease	1.45e-05	4.52e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ALB—Crohn's disease	1.44e-05	4.49e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6—Crohn's disease	1.34e-05	4.2e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.26e-05	3.93e-05	CbGpPWpGaD
